What Traders Can Learn from Diego Forlán About Striking at the Right Time

0 Comments

“Look, technology has made rapid strides, and football is becoming more and more tactical. It’s not easy these days to score at will.”Diego Forlán. Trading is complex and moves fast under market conditions that can change from one moment to the next. Few situations come close to the level of pressure that traders face on […]

How the Heads of JPMorgan’s Startup Banking Team Co-Lead a Team of 550

0 Comments

Sometimes JPMorgan executives receive emails from a colleague who signs off in all caps: JACK. JACK, however, isn’t one person. It’s the shared identity of John China and Andrew Kresse, who co-lead the bank’s Innovation Economy team for founders and venture capital firms. The nickname started as a practical solution, Kresse told Business Insider. “People […]

Where should you buy a home? Crisil maps India’s emerging housing hotspots | Personal Finance

0 Comments

Demand in Tier-2 housing markets has grown at a 14% CAGR over the past five years, but rising prices and affordability concerns are beginning to reshape where—and what—homebuyers should buy, according to a report by Crisil Intelligence.   The report says residential demand across 10 major Tier-2 cities expanded at a 14% compound […]

Stifel reiterates Buy on Liberty Energy stock on power plans

0 Comments

Stifel reiterates Buy on Liberty Energy stock on power plans

IQM Quantum Computers acquires Quantistry software assets

0 Comments

IQM Quantum Computers acquires Quantistry software assets

Solstice to acquire Element Solutions for $14.5 billion

0 Comments

Solstice to acquire Element Solutions for $14.5 billion

Dr Douglas Williams: new drugs and AI will fuel biotech boom

0 Comments

Dr Douglas Williams is a veteran senior executive and board member for several biotech companies. During his time at Biogen, ZymoGenetics, Amgen Immunex and Seattle Genetics, he was involved in the development of several multibillion-dollar treatments, including Enbrel, Tecfidera and Spinraza. Matthew Partridge: The time and cost of clinical trials has been seen as one […]

The Backlash Against Sony Ditching PlayStation Discs Is Not Letting up

0 Comments

The furor over Sony’s decision to stop producing physical PlayStation discs starting in 2028 is not letting up. The gaming giant said earlier this month that it would cease making discs for new games on its consoles due to consumer preferences shifting toward digital releases. A post from Sony last week announcing the news on […]

Constellation Energy: a smart play on the AI energy race

0 Comments

Baltimore-based Constellation Energy, a $90 billion company, generates electricity on a vast scale. And AI’s voracious appetite means that electricity is now becoming a very valuable commodity, and the companies that can generate it reliably, cleanly and at scale will see a lot more attention than they’re currently getting. Investors have re-priced entire industries, assuming […]

Europe Wants Its Own Digital Money Moment

0 Comments

The same question can have both a strategic answer and a practical one. That’s something EU lawmakers are finding out in real time, after the European Parliament’s ECON Committee approved a plan by the European Central Bank to launch a digital euro by 2029. For Europe, the strategic question is no longer whether blockchain-based finance […]